Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


04.03.2019

3 Am J Surg Pathol
1 Ann Oncol
1 BMC Cancer
2 Eur J Obstet Gynecol Reprod Biol
2 Gynecol Oncol
2 Int J Cancer
2 Int J Oncol
1 Lancet Oncol
2 Oncogene
1 PLoS One
1 Tumour Biol


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. ASSEM H, Rambau PF, Lee S, Ogilvie T, et al
    High-grade Endometrioid Carcinoma of the Ovary: A Clinicopathologic Study of 30 Cases.
    Am J Surg Pathol. 2018 Jan 5. doi: 10.1097/PAS.0000000000001016.
    PubMed     Text format     Abstract available

  2. MIRKOVIC J, McFarland M, Garcia E, Sholl LM, et al
    Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Am J Surg Pathol. 2018;42:227-233.
    PubMed     Text format     Abstract available

  3. YANG C, Sun L, Zhang L, Zhou L, et al
    Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary: An Immunohistochemical Study of 70 Cases With Comparison to CDX2, CK7, CK20, Chromogranin, and Synaptophysin.
    Am J Surg Pathol. 2017 Sep 13. doi: 10.1097/PAS.0000000000000951.
    PubMed     Text format     Abstract available


    Ann Oncol

  4. TRIFANESCU OG, Topliceanu F, Gusoiu BA, Gales LN, et al
    24PReactive oxygen species and vascular endothelial growth factor (VEGF) in ovarian cancer patients.
    Ann Oncol. 2019;30.
    PubMed     Text format    


    BMC Cancer

  5. CHEN X, Li X, Wang X, Zhu Q, et al
    MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research.
    BMC Cancer. 2019;19:171.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  6. DUFFY S, Day EK, Bryson G, Millan D, et al
    Malignant tumours arising within mature cystic teratomas of the ovary: Prevalence and clinical outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2017 Dec 21. pii: S0301-2115(17)30571.
    PubMed     Text format    

  7. CORMIO G, Seckl MJ, Loizzi V, Resta L, et al
    Increased human Chorionic Gonadotropin levels five years before diagnosis of an ovarian dysgerminoma.
    Eur J Obstet Gynecol Reprod Biol. 2017 Nov 10. pii: S0301-2115(17)30510.
    PubMed     Text format    


    Gynecol Oncol

  8. MCGUIRE S, Kara B, Hart PC, Montag A, et al
    Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
    Gynecol Oncol. 2019 Feb 20. pii: S0090-8258(19)30059.
    PubMed     Text format     Abstract available

  9. MATSUO K, Machida H, Mandelbaum RS, Grubbs BH, et al
    Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
    Gynecol Oncol. 2019 Feb 20. pii: S0090-8258(19)30106.
    PubMed     Text format     Abstract available


    Int J Cancer

  10. HE Y, Gu Z, Zhu Q, Chen M, et al
    CA125 over-release behavior following a 75-gram oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer.
    Int J Cancer. 2019 Feb 26. doi: 10.1002/ijc.32237.
    PubMed     Text format     Abstract available


  11. Expression of Concern: "Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells" by Hua Yang, Lili He, Patricia Kruk, Santo V. Nicosia and Jin Q. Cheng.
    Int J Cancer. 2019 Feb 27. doi: 10.1002/ijc.32225.
    PubMed     Text format    


    Int J Oncol

  12. LEE J, An S, Jung JH, Kim K, et al
    MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation.
    Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4730.
    PubMed     Text format     Abstract available

  13. CHEN YN, Ren CC, Yang L, Nai MM, et al
    MicroRNA let7d5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
    Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4731.
    PubMed     Text format     Abstract available


    Lancet Oncol

  14. DE BOER SM, Powell ME, Mileshkin L, Katsaros D, et al
    Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
    Lancet Oncol. 2018 Feb 12. pii: S1470-2045(18)30079.
    PubMed     Text format     Abstract available


    Oncogene

  15. INESS AN, Felthousen J, Ananthapadmanabhan V, Sesay F, et al
    The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.
    Oncogene. 2019;38:1080-1092.
    PubMed     Text format     Abstract available

  16. ZHOU W, Sun W, Yung MMH, Dai S, et al
    Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
    Oncogene. 2018;37:3981-3997.
    PubMed     Text format     Abstract available


    PLoS One

  17. GONG W, Liu Y, Seidl C, Dreyer T, et al
    Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
    PLoS One. 2019;14:e0212968.
    PubMed     Text format     Abstract available


    Tumour Biol

  18. RAMALHO S, Andrade LAA, Filho CC, Natal RA, et al
    Role of discoidin domain receptor 2 (DDR2) and microRNA-182 in survival of women with high-grade serous ovarian cancer.
    Tumour Biol. 2019;41:1010428318823988.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: